In response to the current COVID-19 pandemic, it is of paramount importance to rapidly diagnose infections and to develop countermeasures. This project aims to build a high-throughput platform for rapid COVID-19 serodiagnosis, vaccine evaluation, and therapeutics development.
The ongoing SARS-CoV-2 has caused global pandemic. Rapid response to disease control and countermeasure development is a public health priority. The development of a high-throughput platform is a top priority for rapid COVID-19 serodiagnosis, vaccine, and antiviral R&D.
|Bharaj, Preeti; Atkins, Colm; Luthra, Priya et al. (2017) The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication. J Virol 91:|
|van Tol, Sarah; Hage, Adam; Giraldo, Maria Isabel et al. (2017) The TRIMendous Role of TRIMs in Virus-Host Interactions. Vaccines (Basel) 5:|